Sign in

CIK 0000744218 · Large accelerated filer

Celldex Therapeutics, Inc.

Sign in to watch
Ticker
CLDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
133191702
Phone
908-200-7500
Business address
53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
Former names
AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
  1. 8-K Event Material agreement
  2. 10-Q/A Report 10-Q/A
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. ARS Other Annual Report to Security Holders
  6. DEF 14A Proxy Proxy Statement
  7. 8-K Event Material agreement · Executive or director change
  8. 10-K Report Annual Report
  9. 8-K Event Results of operations
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 8-K Event Material agreement

Page 56 of 65 · 1,298 filings